BPA - Maxwell RSC 48 system

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$250,000 to $700,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration is forecasting a Blanket Purchase Agreement (BPA) for the Maxwell RSC 48 system, an analytical laboratory instrument designed for efficient sample extraction and preparation for microbiological analysis. This new requirement will support seven microbiology laboratories across the FDA, with each laboratory expected to receive one unit in FY2026, followed by optional purchases of two additional units annually in subsequent years. The solicitation is estimated to release on December 1, 2025, with contract award anticipated by May 1, 2026.

The estimated award value for this BPA ranges from $250,000 to $700,000, reflecting the base year requirement plus two optional years of procurement. The contract will distribute equipment across seven FDA microbiology labs, with initial deployment in FY2026 and expansion potential through optional years. Interested vendors should direct inquiries to the FDA Acquisition Liaison at hfpacquisitions@fda.hhs.gov for additional information regarding this analytical laboratory instrument manufacturing opportunity classified under NAICS 334516.

Forecast text

BPA - Maxwell RSC 48 system

Base + 2 OY

The Maxwell RSC 48 system is used for efficient extraction to prepare samples for microbiological analysis. This BPA would cover 7 microbiology labs with the expectation that each lab gets one unit if FY26, with the option for two more each year.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast